# name
Disease severity predicts higher healthcare costs among hospitalized nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH) patients in Spain

# metadata.dc.description.abstract[].value
The rising prevalence of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) presents many public health challenges, including a substantial impact on healthcare resource utilization and costs. There are important regional differences in the burden of NAFLD/NASH, and Spain-specific data are lacking. This retrospective, observational study examined the impact of liver disease severity, comorbidities, and demographics on healthcare resource utilization and costs in Spain (...)

# metadata.dc.publisher[].value
Lippincott, Williams & Wilkins. Wolters Kluwer Health

# metadata.dc.rights[].value
cc-by (c) Romero Gómez, Manuel 1967- et al., 2020

# metadata.dc.source[].value
Articles publicats en revistes (Economia)

# metadata.dc.title[].value
Disease severity predicts higher healthcare costs among hospitalized nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH) patients in Spain